mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.4 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.26 |
0.4 |